Protection against oxygen-glucose deprivation/reperfusion injury in cortical neurons by combining omega-3 polyunsaturated acid with Lyciumbarbarum polysaccharide

Nutrients

Volumn 8, Issue 1, 2016, Pages

  Shi, Zhe ^a   Wu, Di ^a   Yao, Jian Ping ^b   Yao, Xiaoli ^b   Huang, Zhijian ^a   Li, Peng ^a   Wan, Jian Bo ^a   He, Chengwei ^a   Su, Huanxing ^a  

^a University of Macau   (Macao)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ca2+; Cortical neurons; DHA; LBP; Neuroprotection; OGD R; Trk B

Indexed keywords

BETA TUBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DOCOSAHEXAENOIC ACID; GLUCOSE; LYCIUM BARBARUM EXTRACT; LYCIUM BARBARUM POLYSACCHARIDE; OMEGA 3 FATTY ACID; OXYGEN; POLYSACCHARIDE; PROTEIN BCL 2; UNCLASSIFIED DRUG; CADHERIN; FATH PROTEIN, MOUSE; HERBACEOUS AGENT; INTRACELLULAR CALCIUM SENSING PROTEIN; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL VIABILITY ASSAY; CONTROLLED STUDY; DNA EXTRACTION; EMBRYO; FATTY ACID ANALYSIS; FEMALE; IMMUNOCYTOCHEMISTRY; LYCIUM BARBARUM; MALE; MOUSE; NONHUMAN; REPERFUSION INJURY; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; CELL HYPOXIA; CELL SURVIVAL; COMBINATION DRUG THERAPY; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; APOPTOSIS; CADHERINS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOCOSAHEXAENOIC ACIDS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; GLUCOSE; INTRACELLULAR CALCIUM-SENSING PROTEINS; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; OXYGEN; RECEPTOR, TRKB; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STROKE;

EID: 84955138966     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8010041     Document Type: Article

References (44)

1. Rothwell, P.M.; Algra, A.; Amarenco, P. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet 2011, 377, 1681–1692. [CrossRef]
2. O’Collins, V.E.; Macleod, M.R.; Donnan, G.A.; Horky, L.L.; van der Worp, B.H.; Howells, D.W. 1026 experimental treatments in acute stroke. Ann. Neurol. 2006, 59, 467–477. [PubMed]
3. Stankowski, J.N.; Gupta, R. Therapeutic targets for neuroprotection in acute ischemic stroke: Lost in translation? Antioxid. Redox Signal. 2011, 14, 1841–1851. [CrossRef] [PubMed]
4. George, P.M.; Steinberg, G.K. Novel stroke therapeutics: Unraveling stroke pathophysiology and its impact on clinical treatments. Neuron 2015, 87, 297–309. [CrossRef] [PubMed]
5. Belayev, L.; Khoutorova, L.; Atkins, K.D.; Bazan, N.G. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 2009, 40, 3121–3126. [CrossRef] [PubMed]
6. Zhang, W.T.; Hu, X.M.; Yang, W.; Gao, Y.Q.; Chen, J. Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions. Stroke 2010, 41, 2341–2347. [CrossRef] [PubMed]
7. Belayev, L.; Khoutorova, L.; Atkins, K.D.; Eady, T.N.; Hong, S.; Lu, Y.; Obenaus, A.; Bazan, N.G. Docosahexaenoic acid therapy of experimental ischemic stroke. Transl. Stroke Res. 2011, 2, 33–41. [CrossRef] [PubMed]
8. Oudin, A.; Wennberg, M. Fish consumption and ischemic stroke in southern sweden. Nutr. J. 2011, 10, 109. [CrossRef] [PubMed]
9. Hu, X.; Zhang, F.; Leak, R.K.; Zhang, W.; Iwai, M.; Stetler, R.A.; Dai, Y.; Zhao, A.; Gao, Y.; Chen, J. Transgenic overproduction of omega-3 polyunsaturated fatty acids provides neuroprotection and enhances endogenous neurogenesis after stroke. Curr. Mol. Med. 2013, 13, 1465–1473. [CrossRef] [PubMed]
10. Zhang, M.; Wang, S.; Mao, L.; Leak, R.K.; Shi, Y.; Zhang, W.; Hu, X.; Sun, B.; Cao, G.; Gao, Y. et al. Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1. J. Neurosci. 2014, 34, 1903–1915. [CrossRef] [PubMed]
11. Kichev, A.; Rousset, C.I.; Baburamani, A.A.; Levison, S.W.; Wood, T.L.; Gressens, P.; Thornton, C.; Hagberg, H. Tnf-related apoptosis-inducing ligand (TRAIL) signaling and cell death in the immature central nervous system after hypoxia-ischemia and inflammation. J. Biol. Chem. 2014, 289, 9430–9439. [CrossRef] [PubMed]
12. Zhang, M.J.; Spite, M. Resolvins: Anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu. Rev. Nutr. 2012, 32, 203–227. [CrossRef] [PubMed]
13. Luo, C.; Ren, H.; Wan, J.B.; Yao, X.; Zhang, X.; He, C.; So, K.F.; Kang, J.X.; Pei, Z.; Su, H. Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury. J. Lipid Res. 2014, 55, 1288–1297. [CrossRef] [PubMed]
14. Cao, D.H.; Xu, J.F.; Xue, R.H.; Zheng, W.F.; Liu, Z.L. Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol. Biochem. Behav. 2004, 79, 651–659. [CrossRef] [PubMed]
15. Siwek, M.; Sowa-Kucma, M.; Dudek, D.; Styczen, K.; Szewczyk, B.; Kotarska, K.; Misztakk, P.; Pilc, A.; Wolak, M.; Nowak, G. Oxidative stress markers in affective disorders. Pharmacol. Rep. 2013, 65, 1558–1571. [CrossRef]
16. Simopoulos, A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: Nutritional implications for chronic diseases. Biomed. Pharmacother. 2006, 60, 502–507. [CrossRef] [PubMed]
17. Kang, J.X.; Wang, J.; Wu, L.; Kang, Z.B. Transgenic mice: Fat-1 mice convert n-6 to !-3 fatty acids. Nature 2004, 427, 504. [CrossRef] [PubMed]
18. Wang, T.; Li, Y.; Wang, Y.; Zhou, R.; Ma, L.; Hao, Y.; Jin, S.; Du, J.; Zhao, C.; Sun, T. et al. Lycium barbarum polysaccharide prevents focal cerebral ischemic injury by inhibiting neuronal apoptosis in mice. PLoS ONE 2014, 9, e90780. [CrossRef] [PubMed]
19. Rui, C.; Yuxiang, L.; Yinju, H.; Qingluan, Z.; Yang, W.; Qipeng, Z.; Hao, W.; Lin, M.; Juan, L.; Chengjun, Z. et al. Protective effects of lycium barbarum polysaccharide on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion. J. Mol. Histol. 2012, 43, 535–542. [CrossRef] [PubMed]
20. Gao, K.; Liu, M.; Cao, J.; Yao, M.; Lu, Y.; Li, J.; Zhu, X.; Yang, Z.; Wen, A. Protective effects of lycium barbarum polysaccharide on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway. Molecules 2015, 20, 293–308. [CrossRef] [PubMed]
21. Wang, H.B.; Li, Y.X.; Hao, Y.J.; Wang, T.F.; Lei, Z.; Wu, Y.; Zhao, Q.P.; Ang, H.; Ma, L.; Liu, J. et al. Neuroprotective effects of LBP on brain ischemic reperfusion neurodegeneration. Eur. Rev. Med. Pharmacol. Sci. 2013, 17, 2760–2765. [PubMed]
22. Ureshino, R.P.; Rocha, K.K.; Lopes, G.S.; Bincoletto, C.; Smaili, S.S. Calcium signaling alterations, oxidative stress, and autophagy in aging. Antioxid. Redox Signal. 2014, 21, 123–137. [CrossRef] [PubMed]
23. Gupta, V.K.; You, Y.; Gupta, V.B.; Klistorner, A.; Graham, S.L. Trkb receptor signalling: Implications in neurodegenerative, psychiatric and proliferative disorders. Int. J. Mol. Sci. 2013, 14, 10122–10142. [CrossRef] [PubMed]
24. Yu, M.S.; Leung, S.K.; Lai, S.W.; Che, C.M.; Zee, S.Y.; So, K.F.; Yuen, W.H.; Chang, R.C. Neuroprotective effects of anti-aging oriental medicine lycium barbarum against beta-amyloid peptide neurotoxicity. Exp. Gerontol. 2005, 40, 716–727. [CrossRef] [PubMed]
25. He, C.; Qu, X.; Cui, L.; Wang, J.; Kang, J.X. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc. Natl. Acad. Sci. USA 2009, 106, 11370–11375. [CrossRef] [PubMed]
26. Liu, Q.; Wu, D.; Ni, N.; Ren, H.; Luo, C.; He, C.; Kang, J.X.; Wan, J.B.; Su, H. Omega-3 polyunsaturated fatty acids protect neural progenitor cells against oxidative injury. Mar. Drugs 2014, 12, 2341–2356. [CrossRef] [PubMed]
27. Wan, J.B.; Huang, L.L.; Rong, R.; Tan, R.; Wang, J.; Kang, J.X. Endogenously decreasing tissue n-6/ω-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein e-deficient mice by inhibiting systemic and vascular inflammation. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 2487–2494. [CrossRef] [PubMed]
28. Doyle, K.P.; Simon, R.P.; Stenzel-Poore, M.P. Mechanisms of ischemic brain damage. Neuropharmacology 2008, 55, 310–318. [CrossRef] [PubMed]
29. Bazan, N.G.; Marcheselli, V.L.; Cole-Edwards, K. Brain response to injury and neurodegeneration: Endogenous neuroprotective signaling. Ann. N. Y. Acad. Sci. 2005, 1053, 137–147. [CrossRef] [PubMed]
30. Kim, H.Y.; Akbar, M.; Kim, K.Y. Inhibition of neuronal apoptosis by polyunsaturated fatty acids. J. Mol. Neurosci. 2001, 16, 223–227. [CrossRef]
31. 2+ homeostasis. J. Neurosci. 2015, 35, 1706–1722. [CrossRef] [PubMed]
32. 2+ release and er stress in astrocytes following in vitro ischemia. J. Neurochem. 2012, 120, 622–630. [CrossRef] [PubMed]
33. Khairallah, R.J.; O’Shea, K.M.; Brown, B.H.; Khanna, N.; des Rosiers, C.; Stanley, W.C. Treatment with docosahexaenoic acid, but not eicosapentaenoic acid, delays Ca2+-induced mitochondria permeability transition in normal and hypertrophied myocardium. J. Pharmacol. Exp. Ther. 2010, 335, 155–162. [CrossRef] [PubMed]
34. Malagelada, C.; Xifro, X.; Minano, A.; Sabria, J.; Rodriguez-Alvarez, J. Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures. Neurobiol. Dis. 2005, 20, 27–37. [CrossRef] [PubMed]
35. Broughton, B.R.; Reutens, D.C.; Sobey, C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40, e331–e339. [CrossRef] [PubMed]
36. Yin, W.; Cao, G.; Johnnides, M.J.; Signore, A.P.; Luo, Y.; Hickey, R.W.; Chen, J. TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiol. Dis. 2006, 21, 358–371. [CrossRef] [PubMed]
37. Zhao, H.; Yenari, M.A.; Cheng, D.; Sapolsky, R.M.; Steinberg, G.K. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome C translocation and caspase-3 activity. J. Neurochem. 2003, 85, 1026–1036. [CrossRef] [PubMed]
38. Cao, G.; Pei, W.; Ge, H.; Liang, Q.; Luo, Y.; Sharp, F.R.; Lu, A.; Ran, R.; Graham, S.H.; Chen, J. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 2002, 22, 5423–5431. [PubMed]
39. Rong, Y.P.; Bultynck, G.; Aromolaran, A.S.; Zhong, F.; Parys, J.B.; de Smedt, H.; Mignery, G.A.; Roderick, H.L.; Bootman, M.D.; Distelhorst, C.W. The BH4 domain of Bcl-2 inhibits er calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc. Natl. Acad. Sci. USA 2009, 106, 14397–14402. [CrossRef] [PubMed]
40. Pinton, P.; Rizzuto, R. Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ. 2006, 13, 1409–1418. [CrossRef] [PubMed]
41. Huang, E.J.; Reichardt, L.F. Trk receptors: Roles in neuronal signal transemuction. Annu. Rev. Biochem. 2003, 72, 609–642. [CrossRef] [PubMed]
42. Balogun, K.A.; Cheema, S.K. The expression of neurotrophins is differentially regulated by omega-3 polyunsaturated fatty acids at weaning and postweaning in C57BL/6 mice cerebral cortex. Neurochem. Int. 2014, 66, 33–42. [CrossRef] [PubMed]
43. Gladman, S.J.; Huang, W.; Lim, S.N.; Dyall, S.C.; Boddy, S.; Kang, J.X.; Knight, M.M.; Priestley, J.V.; Michael-Titus, A.T. Improved outcome after peripheral nerve injury in mice with increased levels of endogenous omega-3 polyunsaturated fatty acids. J. Neurosci. 2012, 32, 563–571. [CrossRef] [PubMed]
44. Kang, J.X. Fat-1 transgenic mice: A new model for omega-3 research. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77, 263–267. [CrossRef] [PubMed]